Antibody Responses to SARS-CoV-2 mRNA Vaccines Are Detectable in Saliva

• Main Authors: Thomas J. Ketas (Author), Devidas Chaturbhuj (Author), Victor M. Cruz Portillo (Author), Erik Francomano (Author), Encouse Golden (Author), Sharanya Chandrasekhar (Author), Gargi Debnath (Author), Randy Diaz-Tapia (Author), Anila Yasmeen (Author), Kyle D. Kramer (Author), Tarek Munawar (Author), Wilhem Leconet (Author), Zhen Zhao (Author), Philip J.M. Brouwer (Author), Melissa M. Cushing (Author), Rogier W. Sanders (Author), Albert Cupo (Author), P.J. Klasse (Author), Silvia C. Formenti (Author), John P. Moore (Author)
• Format: Book
• Published: Case Western Reserve University, 2021-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The approved Pfizer and Moderna mRNA vaccines are well known to induce serum antibody responses to the SARS-CoV-2 Spike (S)-protein. However, their abilities to elicit mucosal immune responses have not been reported. Saliva antibodies represent mucosal responses that may be relevant to how mRNA vacc...